These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6998044)

  • 1. Increased PGI2 activity in venous tissues from rats on oral contraceptives is not prevented by heparin administration before vessel isolation.
    Roncaglioni MC; Di Minno G; de Gaetano G; Donati MB
    Thromb Res; 1980 Jun; 18(6):895-6. PubMed ID: 6998044
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased prostacyclin-like activity in vascular tissues from rats on long-term treatment with an oestrogen-progestagen combination.
    Roncaglioni MC; di Minno G; Reyers I; de Gaetano G; Donati MB
    Thromb Res; 1979; 14(4-5):793-7. PubMed ID: 384594
    [No Abstract]   [Full Text] [Related]  

  • 3. Oestrogen containing oral contraceptives decrease prostacyclin production.
    Ylikorkala O; Puolakka J; Viinikka L
    Lancet; 1981 Jan; 1(8210):42. PubMed ID: 6109074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of proteoglycans (Pg) and glycosaminoglycans (GAG) on prostacyclin (PGI2) and PGI2-formation of rat arteries.
    Klein K; Stachelberger H; Sinzinger H; Silberbauer K; Leithner C
    Artery; 1980; 8(1):37-42. PubMed ID: 7000041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in inhibition of PGI2 production by aspirin in rabbit artery and vein segments.
    Buchanan MR; Dejana E; Cazenave JP; Richardson M; Mustard JF; Hirsh J
    Thromb Res; 1980 Nov; 20(4):447-60. PubMed ID: 7010667
    [No Abstract]   [Full Text] [Related]  

  • 6. Is the variation in the susceptibility of various species to atherosclerosis due to inborn differences in prostacyclin (PGI2) formation.
    Sinzinger H; Clopath P; Silberbauer K; Winter M
    Experientia; 1980 Mar; 36(3):321-3. PubMed ID: 6989625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Warfarin and heparin interaction with prostacyclin-like activity generated by arterial wall in the rat.
    Doni MG; Piva E
    Thromb Haemost; 1983 Jun; 49(3):228-9. PubMed ID: 6348997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uncontrolled PGI2 production by whole vessel wall segments due to thrombin generation in vivo and its prevention by heparin.
    Buchanan MR; Dejana E; Cazenave JP; Mustard JF; Hirsh J
    Thromb Res; 1979; 16(3-4):551-5. PubMed ID: 390762
    [No Abstract]   [Full Text] [Related]  

  • 9. Oestrogen containing oral contraceptives, decreased prostacyclin production, and haemolytic uraemic syndrome.
    Hauglustaine D; Vanrenterghem Y; Michielsen OP; van Damme B
    Lancet; 1981 Feb; 1(8215):328-9. PubMed ID: 6109966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of PGI2 (prostacyclin) synthesis in the arterial wall enhances the formation of white platelet thrombi in vivo.
    Bourgain RH
    Haemostasis; 1978; 7(4):252-5. PubMed ID: 95991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of heparin on prostacyclin activity of the aorta wall].
    Baluda VP; Sushkevich GN; Liasko LI
    Biull Eksp Biol Med; 1982 Sep; 94(9):79-80. PubMed ID: 6756506
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet adhesion and mural platelet thrombus formation on aortic subendothelium of rats, rabbits, and guinea pigs correlate negatively with the vascular PGI2 production.
    Tschopp TB; Baumgartner HR
    J Lab Clin Med; 1981 Sep; 98(3):402-11. PubMed ID: 7021720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The time course and magnitude of prostacyclin (PGI2) production by rat aortic rings incubated in human plasma.
    Ritter JM; Orchard MA; Blair IA; Lewis PJ
    Biochem Pharmacol; 1982 Mar; 31(6):1163-5. PubMed ID: 7044384
    [No Abstract]   [Full Text] [Related]  

  • 14. Dipyridamole: a potent stimulator of prostacyclin (PGI2) biosynthesis.
    Blass KE; Block HU; Förster W; Pönicke K
    Br J Pharmacol; 1980 Jan; 68(1):71-3. PubMed ID: 6766769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin control of venous thromboembolism.
    Dale WA; Lewis MR
    Arch Surg; 1970 Dec; 101(6):744-55. PubMed ID: 5489300
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of the inhibition of PGI2-synthetase and lipoxygenase and of arachidonic acid on platelet-vessel wall interaction.
    Bourgain RH; Andries R; Finne E; Vanden Driessche RJ; Bernard PJ
    Arch Int Pharmacodyn Ther; 1982 Oct; 259(2):305-7. PubMed ID: 6817724
    [No Abstract]   [Full Text] [Related]  

  • 17. The inhibition of PGI2 synthetase within the arterial wall by 15-hydroperoxyarachidonic acid enhances local white platelet thrombosis.
    Bourgain RH
    Haemostasis; 1980; 9(6):345-51. PubMed ID: 6778799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostacyclin production by isolated adipocytes.
    Axelrod L; Levine L
    Diabetes; 1981 Feb; 30(2):163-7. PubMed ID: 7009268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of prostacyclin (PGI2) formation in the rat small-intestine and gastric mucosa by the ulcerogen, indomethacin [proceedings].
    Whittle BJ
    Br J Pharmacol; 1978 Nov; 64(3):438P. PubMed ID: 363210
    [No Abstract]   [Full Text] [Related]  

  • 20. Failure of salicylate to reduce inhibition of human venous prostacyclin in synthesis by conventional dose aspirin.
    Hanley SP; Hughes J
    Thromb Haemost; 1983 Feb; 49(1):51-2. PubMed ID: 6342201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.